Potential effects of a national consensus statement on optimal treatment of early rheumatoid arthritis in Ontario

Scand J Rheumatol. 2009;38(5):390-1. doi: 10.1080/03009740902842190.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Consensus Development Conferences as Topic*
  • Humans
  • Methotrexate / therapeutic use
  • Ontario

Substances

  • Antirheumatic Agents
  • Methotrexate